These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12293)

  • 1. A study into the prediction of mass transfer of sulphathiazole in aqueous suspension during crystal growth [proceedings].
    Carless JE; Jordan D
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():2P. PubMed ID: 12293
    [No Abstract]   [Full Text] [Related]  

  • 2. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal growth in aqueous suspensions.
    Varney G
    J Pharm Pharmacol; 1967 Dec; 19():Suppl:19S-23S. PubMed ID: 4383851
    [No Abstract]   [Full Text] [Related]  

  • 4. The crystallization behaviour of sulphathiazole.
    Jordan D; Carless JE
    J Pharm Pharmacol; 1976 May; 28(5):410-4. PubMed ID: 6748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: A study of the in vitro dissolution behaviour of different brands of sulphathiazole tablets and tetracycline hydrochloride capsules.
    York P
    West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):91P. PubMed ID: 4470659
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated crystal growth of sulphathiazole by temperature cycling.
    Carless JE; Foster AA
    J Pharm Pharmacol; 1966 Nov; 18(11):697-708. PubMed ID: 4382045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Principles of retardation].
    Hüttenrauch R
    Pharmazie; 1975 Jan; 30(1):3-16. PubMed ID: 1094473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electron-microscopic studies on the texture of sulphathiazole and sulphathiazole tablets (author's transl)].
    Kedvessy G; Selmeczi B; Pintye-Hódi K; Kala H; Moldenhauer H; Giese R
    Pharmazie; 1982 Feb; 37(2):132-4. PubMed ID: 7071119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of differential scanning calorimetry to the study of sulphathiazole crystal forms.
    Moustafa MA; Carless JE
    J Pharm Pharmacol; 1969 Jun; 21(6):359-65. PubMed ID: 4389558
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of crystal form on the radial stress transmission characteristics of pharmaceutical materials.
    Summers MP; Enever RP; Carless JE
    J Pharm Pharmacol; 1976 Feb; 28(2):89-99. PubMed ID: 6687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinylsulfathiazole crystal forms. III: Crystal growth studies.
    Moustafa MA; Ebian AR; Khalil SA; Motawi MM
    J Pharm Sci; 1975 Sep; 64(9):1485-9. PubMed ID: 1185562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-friendly synthesis of ZnO nanoparticles in aqueous solution at near-neutral pH and low temperature.
    Bauermann LP; Bill J; Aldinger F
    J Phys Chem B; 2006 Mar; 110(11):5182-5. PubMed ID: 16539445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution electron microscopy study of sulphathiazole crystals.
    Luklinska ZH; Solanke OO; Summers MP
    J Pharm Pharmacol; 1989 Aug; 41(8):559-61. PubMed ID: 2571701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth.
    Lindfors L; Skantze P; Skantze U; Westergren J; Olsson U
    Langmuir; 2007 Sep; 23(19):9866-74. PubMed ID: 17696457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational model for the prediction of aqueous solubility that includes crystal packing, intrinsic solubility, and ionization effects.
    Johnson SR; Chen XQ; Murphy D; Gudmundsson O
    Mol Pharm; 2007; 4(4):513-23. PubMed ID: 17539661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on liberation of active substances from ointment bases. II. Influence of Tween 80, Span 60, water and physico-chemical structure of the ointment on sulphathiazole liberation from white petrolatum.
    Olszewski Z; Kubis A
    Acta Pol Pharm; 1972; 29(6):608-17. PubMed ID: 4670138
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water mediates the metastable crystal-to-stable crystal phase transition process in phospholipid aqueous dispersion.
    Wu FG; Chen L; Yu ZW
    J Phys Chem B; 2009 Jan; 113(4):869-72. PubMed ID: 19125632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.